Russell Investments Group, Ltd. - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 34 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.6%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,411
-99.2%
321
-99.0%
0.00%
-100.0%
Q3 2021$298,000
-63.7%
31,728
-71.8%
0.00%0.0%
Q2 2021$820,000
-32.7%
112,584
-42.7%
0.00%
-50.0%
Q1 2021$1,219,000
-24.8%
196,477
-9.9%
0.00%
-33.3%
Q4 2020$1,622,000
+22.9%
218,1190.0%0.00%0.0%
Q3 2020$1,320,000
+641.6%
218,119
+675.3%
0.00%
Q4 2018$178,00028,1320.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders